Background: Venous thromboembolism (VTE) remains a leading cause of maternal morbidity and mortality following cesarean section. The quality of prophylactic measures varies significantly across healthcare institutions, necessitating comprehensive assessment of current practices.

Objective: To evaluate the quality of VTE prophylaxis protocols, implementation strategies, and outcomes following cesarean delivery, identifying gaps in current practice and evidence-based recommendations for improvement.

venous thromboembolism, cesarean section, prophylaxis, quality assessment, maternal safety

Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018;2(22):3317-3359. doi:10.1182/bloodadvances.2018024802

Knight M, Tuffnell D, Kenyon S, et al. Saving Lives, Improving Mothers’ Care: Lessons learned to inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2014–16. MBRRACE-UK, 2018.

Sultan AA, West J, Grainge MJ, et al. Risk of first venous thromboembolism in and around pregnancy: a population-based cohort study. BMJ. 2012;345:e6363. doi:10.1136/bmj.e6363

ACOG Practice Bulletin No. 196. Thromboembolism in Pregnancy. Obstet Gynecol. 2018;132(1):e1-e17. doi:10.1097/AOG.0000000000002706

National Institute for Health and Care Excellence (NICE). Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. NICE guideline [NG89]. 2018.

James AH. Prevention and management of thromboembolism in pregnancy. Am J Med. 2007;120(10 Suppl 2):S26-34. doi:10.1016/j.amjmed.2007.07.012

Pomp ER, Lenselink AM, Rosendaal FR, Doggen CJ. Pregnancy, the postpartum period and prothrombotic defects: risk of venous thrombosis in the MEGA study. J Thromb Haemost. 2008;6(4):632-637. doi:10.1111/j.1538-7836.2008.02921.x

Bates SM, Greer IA, Middeldorp S, Veenstra DL, Prabulos AM, Vandvik PO. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis. Chest. 2012;141(2_suppl):e691S-e736S.

RCOG Green-top Guideline No. 37a. Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium. Royal College of Obstetricians and Gynaecologists, 2015.

Langen E, Streiff MB, Sachs BP, Bauersachs R, Heit JA. Venous thromboembolism in women: current status and challenges. Lancet Haematol. 2021;8(3):e209-e220. doi:10.1016/S2352-3026(20)30356-3

D'Alton ME, Friedman AM, Smiley RM, et al. National Partnership for Maternal Safety: Consensus Bundle on Venous Thromboembolism. Obstet Gynecol. 2016;128(4):688-696. doi:10.1097/AOG.0000000000001647

Lindqvist PG, Torsson J, Almqvist Y, Björgell O. Thromboprophylaxis use and risk assessment in elective cesarean deliveries in Sweden: a national survey. Acta Obstet Gynecol Scand. 2019;98(3):365-372. doi:10.1111/aogs.13500

Chan WS, Rey E, Kent NE, et al. Venous thromboembolism and antithrombotic therapy in pregnancy. J Obstet Gynaecol Can. 2014;36(6):527-553. doi:10.1016/S1701-2163(15)30500-6

Owens MY, Villarreal A, Shah A, et al. Evaluation of a risk-based thromboprophylaxis protocol for cesarean deliveries: a cohort study. Am J Perinatol. 2018;35(4):354-359. doi:10.1055/s-0037-1606355

Jacobson BF, Louw S, Büller H, et al. Venous thromboembolism: prophylactic and therapeutic practice guideline. S Afr Med J. 2013;103(4 Pt 2):261-267. doi:10.7196/SAMJ.6706

Ferres MA, Newman TB, Gao C, et al. Impact of a quality improvement bundle on compliance with guidelines for prevention of venous thromboembolism in cesarean deliveries. J Matern Fetal Neonatal Med. 2021;34(19):3247-3252. doi:10.1080/14767058.2019.1697546

A